Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

Heparin is cheap and essential to millions of hospitalized people. Tariffs could disrupt the supply chain that gets ...

Soaring consumer inflation expectations, driven to a level not seen since the early 1980s, coupled with jittery markets and ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

With the new manufacturing capacity, 100% of its key medicines for U.S. patients will be made in the U.S., Novartis said late ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Pharmaceutical and cosmetics packager Gerresheimer posted higher revenue and adjusted earnings for the first quarter, boosted by the consolidation of Bormioli Pharma, which it bought last year.

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

The Japan gynecological benign tumor market is witnessing remarkable expansion, with market revenues expected to grow from approximately US$ 1,877.78 million in 2023 to an estimated US$ 4,315.65 ...

US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...

While the informal trade talks continue, the U.S. market has shown signs of improvement. It’s been nearly a month since a major bird flu outbreak impacted egg-laying hens, the department said.